United Therapeutics Corporation
United Therapeutics Corporation
1040 Spring Street
Silver Spring, MD 20910
Phone: (301) 608-9292Website: https://www.unither.com/Careers: www.unither.com/careers.html
Latest news
- United Therapeutics Announces FDA Approval of the Implantable System for Remodulin
31 July 2018 - FDA Approves Unituxin (dinutuximab) for Pediatric High-Risk Neuroblastoma
10 March 2015 - FDA Approves Orenitram (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension
30 December 2013 - United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA
12 September 2013
Drugs Associated with United Therapeutics Corporation
United Therapeutics Corporation manufactures, markets and/or distributes more than 5 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Adcirca
Generic name: tadalafil Drug class: agents for pulmonary hypertension |
7 reviews | 6.6 / 10 |
|
Orenitram
Generic name: treprostinil Drug class: agents for pulmonary hypertension |
1 review | 8.0 / 10 |
|
Remodulin
Generic name: treprostinil Drug class: agents for pulmonary hypertension |
5 reviews | 5.6 / 10 |
|
Tyvaso
Generic name: treprostinil Drug class: agents for pulmonary hypertension |
17 reviews | 7.2 / 10 |
|
Unituxin
Generic name: dinutuximab Drug class: miscellaneous antineoplastics |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
